Home NDC 50192-113 CAMBIA
Product NDC 50192-113
11-digit product format 501920113
Labeler code 50192
Product ID 50192-113_3a38ddb1-2e6b-406e-8992-a1c9cbd9acd0
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Diclofenac Potassium
Dosage form POWDER, FOR SOLUTION
Route ORAL
Labeler Nautilus Neurosciences, Inc.
Application NDA022165
Marketing category NDA
Marketing start 2010-04-20
Marketing end 0000-00-00
Substance DICLOFENAC POTASSIUM
Active strength 1 mg/mg
Pharmacologic classes Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 2 · 66 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022165-001 CAMBIA DICLOFENAC POTASSIUM 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N022165-001 AB
Orange Book patents# Current patent rows page 1 of 1 · 4 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N022165-001 7759394 2026-06-16 U-436 Drug substance, Drug product N022165-001 8097651 2026-06-16 U-436 Drug substance, Drug product N022165-001 8927604 2026-06-16 U-436 2015-01-21 N022165-001 9827197 2026-06-16 Drug product 2017-12-05
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N022165-001 CAMBIA 50MG FOR SOLUTION / ORAL AB RLD, RS 2009-06-17 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
Observed Orange Book patent history# Patent history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N022165-001 7759394 2026-06-16 U-436 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022165-001 8097651 2026-06-16 U-436 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022165-001 8927604 2026-06-16 U-436 2015-01-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022165-001 9827197 2026-06-16 Drug product 2017-12-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022165-001 7759394 2026-06-16 U-436 Drug substance, Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022165-001 8097651 2026-06-16 U-436 Drug substance, Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022165-001 8927604 2026-06-16 U-436 2015-01-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022165-001 9827197 2026-06-16 Drug product 2017-12-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022165-001 7759394 2026-06-16 U-436 Drug substance, Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022165-001 8097651 2026-06-16 U-436 Drug substance, Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022165-001 8927604 2026-06-16 U-436 2015-01-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022165-001 9827197 2026-06-16 Drug product 2017-12-05 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022165-001 7759394 2026-06-16 U-436 Drug substance, Drug product fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022165-001 8097651 2026-06-16 U-436 Drug substance, Drug product fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022165-001 8927604 2026-06-16 U-436 2015-01-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022165-001 9827197 2026-06-16 Drug product 2017-12-05 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022165-001 7759394 2026-06-16 U-436 Drug substance, Drug product b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022165-001 8097651 2026-06-16 U-436 Drug substance, Drug product b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022165-001 8927604 2026-06-16 U-436 2015-01-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022165-001 9827197 2026-06-16 Drug product 2017-12-05 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022165-001 7759394 2026-06-16 U-436 Drug substance, Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022165-001 8097651 2026-06-16 U-436 Drug substance, Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022165-001 8927604 2026-06-16 U-436 2015-01-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022165-001 9827197 2026-06-16 Drug product 2017-12-05 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022165-001 7759394 2026-06-16 U-436 Drug substance, Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022165-001 8097651 2026-06-16 U-436 Drug substance, Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022165-001 8927604 2026-06-16 U-436 2015-01-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022165-001 9827197 2026-06-16 Drug product 2017-12-05 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022165-001 7759394 2026-06-16 U-436 Drug substance, Drug product 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022165-001 8097651 2026-06-16 U-436 Drug substance, Drug product 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022165-001 8927604 2026-06-16 U-436 2015-01-21 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022165-001 9827197 2026-06-16 Drug product 2017-12-05 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022165-001 7759394 2026-06-16 U-436 Drug substance, Drug product d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022165-001 8097651 2026-06-16 U-436 Drug substance, Drug product d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022165-001 8927604 2026-06-16 U-436 2015-01-21 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022165-001 9827197 2026-06-16 Drug product 2017-12-05 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022165-001 7759394 2026-06-16 U-436 Drug substance, Drug product d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022165-001 8097651 2026-06-16 U-436 Drug substance, Drug product d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022165-001 8927604 2026-06-16 U-436 2015-01-21 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022165-001 9827197 2026-06-16 Drug product 2017-12-05 d06236e962d9…
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50192-113-01 CAMBIA 50 mg in 1 PACKET POWDER, FOR SOLUTION 50 4 50192-113-09 CAMBIA 50 mg in 1 PACKET POWDER, FOR SOLUTION 50 4 50192-113-09 CAMBIA 09 in 1 BOX POWDER, FOR SOLUTION 09 4
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded DICLOFENAC POTASSIUM ACTIVE INGREDIENT L4D5UA6CB4 CAMBIA (DICLOFENAC POTASSIUM) POWDER, FOR SOLUTION [NAUTILUS NEUROSCIENCES, INC.] 4 DICLOFENAC ACTIVE MOIETY 144O8QL0L1 CAMBIA (DICLOFENAC POTASSIUM) POWDER, FOR SOLUTION [NAUTILUS NEUROSCIENCES, INC.] 4 ASPARTAME INACTIVE INGREDIENT Z0H242BBR1 CAMBIA (DICLOFENAC POTASSIUM) POWDER, FOR SOLUTION [NAUTILUS NEUROSCIENCES, INC.] 4 GLYCERYL BEHENATE INACTIVE INGREDIENT R8WTH25YS2 CAMBIA (DICLOFENAC POTASSIUM) POWDER, FOR SOLUTION [NAUTILUS NEUROSCIENCES, INC.] 4 MANNITOL INACTIVE INGREDIENT 3OWL53L36A CAMBIA (DICLOFENAC POTASSIUM) POWDER, FOR SOLUTION [NAUTILUS NEUROSCIENCES, INC.] 4 POTASSIUM BICARBONATE INACTIVE INGREDIENT HM5Z15LEBN CAMBIA (DICLOFENAC POTASSIUM) POWDER, FOR SOLUTION [NAUTILUS NEUROSCIENCES, INC.] 4 SACCHARIN SODIUM INACTIVE INGREDIENT SB8ZUX40TY CAMBIA (DICLOFENAC POTASSIUM) POWDER, FOR SOLUTION [NAUTILUS NEUROSCIENCES, INC.] 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50192-113 CAMBIA (DICLOFENAC POTASSIUM) POWDER, FOR SOLUTION [NAUTILUS NEUROSCIENCES, INC.] 4 Legacy NDC, 3 package rows 20120402_d7335594-50c9-4ae2-a3e3-b9a375187b62.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Status 50192-113-01 50192011301 50 mg in 1 PACKET 50 mg Historical 50192-113-09 50192011309 50 mg in 1 PACKET 50 mg Historical